Epi One, Inc. is a biotechnology startup based in the United States, focused on revolutionizing cancer diagnosis. Founded in 2016, the company's mission revolves around addressing the significant challenge of early cancer prognosis, detection, and the prediction of post-diagnosis drug response. Epi One, Inc. aims to leverage advanced technology to elevate cancer diagnosis to the next level. Recently, the company received a $1.00M Angel Round investment on 08 March 2024. With a strong focus on biotechnology and healthcare, Epi One, Inc. is making strides in the critical fight against cancer, positioning itself as a significant player in the industry.
